These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 14636244)

  • 1. The inducibility of TNF-alpha production is different in the granulocytic and monocytic differentiated forms of wild type and CGD-mutant PLB-985 cells.
    Selmeczy Z; Szelényi J; Német K; Vizi ES
    Immunol Cell Biol; 2003 Dec; 81(6):472-9. PubMed ID: 14636244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged ethanol treatment enhances lipopolysaccharide/phorbol myristate acetate-induced tumor necrosis factor-alpha production in human monocytic cells.
    Zhang Z; Bagby GJ; Stoltz D; Oliver P; Schwarzenberger PO; Kolls JK
    Alcohol Clin Exp Res; 2001 Mar; 25(3):444-9. PubMed ID: 11290857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphonuclear leukocyte dysfunction syndrome in patients with increasing sepsis severity.
    Kaufmann I; Hoelzl A; Schliephake F; Hummel T; Chouker A; Peter K; Thiel M
    Shock; 2006 Sep; 26(3):254-61. PubMed ID: 16912650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of superoxide production in monocytes from patients with chronic granulomatous disease by recombinant cytokines.
    Jendrossek V; Peters AM; Buth S; Liese J; Wintergerst U; Belohradsky BH; Gahr M
    Blood; 1993 Apr; 81(8):2131-6. PubMed ID: 8386028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficient priming activity of newborn cord blood-derived polymorphonuclear neutrophilic granulocytes with lipopolysaccharide and tumor necrosis factor-alpha triggered with formyl-methionyl-leucyl-phenylalanine.
    Bortolussi R; Howlett S; Rajaraman K; Halperin S
    Pediatr Res; 1993 Sep; 34(3):243-8. PubMed ID: 8134162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic ethanol enhances ectodomain shedding in T cells and monocytes.
    Zhao XJ; Oliver P; Song K; Schurr J; Zhang Z; Kolls JK
    Alcohol Clin Exp Res; 2004 Sep; 28(9):1399-407. PubMed ID: 15365312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zymosan and PMA activate the immune responses of Mutz3-derived dendritic cells synergistically.
    Song JS; Kim YJ; Han KU; Yoon BD; Kim JW
    Immunol Lett; 2015 Sep; 167(1):41-6. PubMed ID: 26183538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of human monocyte superoxide production by recombinant interleukin-3.
    Jendrossek V; Buth S; Stetter C; Gahr M
    Agents Actions; 1992 Sep; 37(1-2):127-33. PubMed ID: 1333725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased tumour necrosis factor-α production by monocytes of granulomatosis with polyangiitis.
    Park J; Lee EB; Song YW
    Scand J Rheumatol; 2014; 43(5):403-8. PubMed ID: 24898149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalidomide attenuates excessive inflammation without interrupting lipopolysaccharide-driven inflammatory cytokine production in chronic granulomatous disease.
    Kawai T; Watanabe N; Yokoyama M; Arai K; Oana S; Harayama S; Yasui K; Oh-Ishi T; Onodera M
    Clin Immunol; 2013 May; 147(2):122-8. PubMed ID: 23583898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma.
    Galve-de Rochemonteix B; Nicod LP; Dayer JM
    Am J Respir Cell Mol Biol; 1996 Mar; 14(3):279-87. PubMed ID: 8845179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic granulomatous disease. Expression of the metabolic defect by in vitro culture of bone marrow progenitors.
    Newburger PE; Kruskall MS; Rappeport JM; Robinson SH; Chovaniec ME; Cohen HJ
    J Clin Invest; 1980 Sep; 66(3):599-602. PubMed ID: 6249853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosyl-phosphatidyl-inositol-defective granulocytes from paroxysmal nocturnal haemoglobinuria patients show increased bacterial ingestion but reduced respiratory burst induction.
    Cacciapuoti C; Terrazzano G; Barone L; Sica M; Becchimanzi C; Rotoli B; Ruggiero G; Alfinito F
    Am J Hematol; 2007 Feb; 82(2):98-107. PubMed ID: 17013814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
    Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
    Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunodepressive effects of LPS on monocyte CD14 in vivo.
    Hojman H; Lounsbury D; Harris H; Horn JK
    J Surg Res; 1997 Apr; 69(1):7-10. PubMed ID: 9202639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staining of eosinophils with nitroblue tetrazolium in patients with chronic granulomatous disease.
    Roberts RL; Ohno Y; Gallin JI
    Pediatr Res; 1986 Apr; 20(4):378-80. PubMed ID: 2422626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic neutropenia and defect in superoxide generation of granulocytes in two patients: enhancement of bactericidal capacity and respiratory burst activity by treatment with recombinant human granulocyte colony-stimulating factor.
    Káposzta R; Maródi L
    Pediatr Res; 1995 Jan; 37(1):50-5. PubMed ID: 7535420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. M5, a phosphoinositol-linked human myelomonocytic activation-associated antigen.
    Gadd SJ; Majdic O; Kasinrerk W; Stockinger H; Maurer D; Eher R; Knapp W
    Clin Exp Immunol; 1990 May; 80(2):252-6. PubMed ID: 2357854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradoxical stimulation and inhibition by protein kinase C modulating agents of lipopolysaccharide evoked production of tumour necrosis factor in human monocytes.
    Coffey RG; Weakland LL; Alberts VA
    Immunology; 1992 May; 76(1):48-54. PubMed ID: 1628900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a nonoxidative mechanism of human natural killer (NK) cell cytotoxicity by using mononuclear effector cells from healthy donors and from patients with chronic granulomatous disease.
    Kay HD; Smith DL; Sullivan G; Mandell GL; Donowitz GR
    J Immunol; 1983 Oct; 131(4):1784-8. PubMed ID: 6311897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.